why choose us

First received: February 09, 2023

Clinical Trial: A Study of Immune Suppression Treatment for People With Sickle Cell Disease or ?-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)

Study Status: Completed

Recruit Status: RECRUITING

Condition: Sickle Cell Disease

Study Type: INTERVENTIONAL


Official Title: Pre-Transplant Immune Suppression With Hematopoietic Cell Transplantation From Haploidentical Donors for Adults and Children With Sickle Cell Disease or ß-Thalassemia (Haplo PTCy)

Brief Summary: Hematopoietic Cell Transplantation/HCT involves receiving healthy blood-forming cells (stem cells) from a donor to replace the diseased or damaged cells in participants' bone marrow.The researchers think giving participants treatment with fludarabine and dexamethasone, drugs that lower the activity of the body's immune system (immune suppression), before standard conditioning therapy and HCT may help prevent serious side effects, including graft failure and GvHD.In this study, depending on how…

Read more